Jackie Ilacqua, head of oncology, Synovate
pharmafile | November 2, 2009 | Appointment | Sales and Marketing | appointment, sales and marketing, synovate
Synovate has appointed Jackie Ilacqua to the newly-created role of head of oncology.
Formerly responsible for building and managing Synovate’s global Oncology Monitor, Ilacqua, based in the US, is now tasked with continuing to develop the agency’s portfolio of services within Oncology.
She has been at Synovate for 18 years having joined the company (then Tandem Research) in 1991. She has over 18 years of therapy area focussed research experience, the last four of which have been solely dedicated to Oncology.
Commented Bob Douglas, Global Head of Synovate Healthcare: “Oncology is the largest pharmaceutical market in the world and continues to show good growth. Our recent expansion of our global Oncology Monitor is testament to that.
“Jackie’s appointment to this role is a demonstration of our commitment to this important field of research – she has the Oncology experience and extensive know – how to ensure that we are delivering the best the industry has to offer in this area, on both a global and local market level.”
Ilacqua will continue to lead Synovate’s Global Oncology Monitor.
Related Content
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …
Lonza CEO to step down in 2020
It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …